Vasamed, Inc. (VSMD)
Vasamed, Inc. operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Eden Prairie, MN, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $802. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -352.6%. Its beta of -1.01 implies it has historically moved less than the broad market.
Vasamed, Inc. specializes in the development, manufacturing, licensing, and distribution of a comprehensive suite of products, software solutions, and services focused on the assessment and management of circulatory health throughout the United States. Key among its offerings is the SensiLase PAD-IQ, a device designed to measure skin perfusion pressure, conduct pulse volume recordings, and calculate the Ankle-Brachial Index utilizing Doppler-derived pressure readings. The company also provides advanced Wound Imaging & SmartDraw systems for precise wound measurement. Additionally, Vasamed offers the PAD-IQ Studycast, a platform that facilitates the rapid and secure transmission of diagnostic test results to vascular specialists. This enables prompt interpretation of findings and supports timely, medically indicated therapeutic interventions. For safeguarding its equipment, the company also supplies a custom carrying case for the PAD-IQ system. Vasamed caters to both clinicians and patients, and has been operating since its founding in 1988. Its corporate headquarters are located in Eden Prairie, Minnesota.
Vasamed, Inc. is most often compared with the following Healthcare names: